VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
Tracheal Cartilaginous Sleeve in Syndromic Craniosynostosis: An Underrecognized Source of Significant Morbidity and Mortality.
Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: Application to an oral bioavailability study of genistein in mice.
Peripheral Nerve Stimulation for Back Pain in Patients With Multiple Myeloma as Bridge Therapy to Radiation Treatment: A Case Series.
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology. 2012 Apr; 142(4):1021-1031.e15.
View in:
PubMed
subject areas
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Belgium
Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Blotting, Western
Cell Line, Tumor
Cell Proliferation
Chi-Square Distribution
Cholangiocarcinoma
Cluster Analysis
ErbB Receptors
Female
Gene Expression Profiling
Genetic Predisposition to Disease
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Laser Capture Microdissection
Male
Middle Aged
Molecular Targeted Therapy
Mutation
Oligonucleotide Array Sequence Analysis
Patient Selection
Phenotype
Precision Medicine
Prognosis
Proportional Hazards Models
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins p21(ras)
Queensland
Quinazolines
ras Proteins
Risk Assessment
Risk Factors
Survival Rate
Time Factors
Trastuzumab
Tumor Microenvironment
United States
authors with profiles
BORIS BLECHACZ